GILEAD SCIENCES, INC. R&D Expense 2011-2020 | GILD
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is GILEAD SCIENCES, INC.'s current r&d expense?
GILEAD SCIENCES, INC. (GILD) annual r&d expense for 2019 was $9.11B, a 81.47% increase from 2018. GILEAD SCIENCES, INC. r&d expense for the quarter ending March 31, 2020 was $1.10B.
What was GILEAD SCIENCES, INC.'s r&d expense in 2018?
GILEAD SCIENCES, INC. annual r&d expense for 2018 was $5.02B, a 34.39% increase from 2017.
What was GILEAD SCIENCES, INC.'s r&d expense in 2017?
GILEAD SCIENCES, INC. annual r&d expense for 2017 was $3.73B, a 26.76% decline from 2016.
What is GILEAD SCIENCES, INC.'s 5-year r&d expense CAGR?
GILEAD SCIENCES, INC. r&d expense grew at a compound annual growth rate (CAGR) of 26.12% from FY2014 to FY2019, going from $2.85B to $9.11B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+26.1%
FY2014
$2.85B
→
FY2019
$9.11B
111213141516171819
5 years selected
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →